
The US Import Compliance Analyst supports the supply chain activities across nine North American Marketing and Production Unit locations, spanning Fresenius Kabi (Pharma) and Fenwal (MedTech) divisions. The position ensures adherence to import regulations and formal control procedures, managing the timely and compliant flow of international shipments. Responsibilities include monitoring the performance of external customs brokerage partners, managing import documentation, obtaining necessary permits, and maintaining regulatory databases. The role also involves project management for high-profile U.S. import launches, cost analysis, and audit activities to ensure compliance, identify efficiencies, and provide training. It plays a key part in supporting the Supply Chain Security Program (C-TPAT) and continuous improvement initiatives.
*This position requires working onsite at one of our Distribution Centers (Pleasant Prairie, WI; Duncan, SC; or Las Vegas, NV), or at our Lake Zurich, IL US headquarters 3+ days per week. Priority will be given to candidates in Illinois or Wisconsin.
*This position is not eligible for visa sponsorship either now or in the future.
We offer an excellent salary and benefits package including medical, dental and vision coverage, as well as life insurance, disability, 401K with company contribution, and wellness program.
Please note that joining our team does not create a guaranteed or permanent employment arrangement. All employment is at‑will, meaning both the employee and Fresenius Kabi have the right to end the employment relationship at any time, in accordance with applicable federal and state laws.
Fresenius Kabi is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, citizenship, immigration status, disabilities, or protected veteran status.

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint